Natalia Rumas, MD

Vice-Chair, EMRA Toxicology Division, Boston Medical Center, Boston, MA

NULL
Mad as a Hatter: Physostigmine for Delirium Control in Anticholinergic Toxicity A 34-year-old female with a history of bipolar disorder, depression, and multiple previous suicide attempts is brought
NULL
Emerging Drugs of Abuse A number of new synthetic drugs have penetrated the United States markets and our emergency departments over the past several years. Poison control centers have experienced an
CHAT NOW
CHAT OFFLINE